🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 03969K108
- Market Cap
- Mid Cap
- IPO
- 1/31/2020 · $17.00/share
Business: Arcutis Biotherapeutics is a late-stage biopharmaceutical company focused on developing and commercializing treatments for unmet needs in immune-mediated dermatological diseases and conditions, or immuno-dermatology.
Company Contact
- CEO
- Frank Watanabe
- CFO
- John W. Smither
- Headquarters
- 2945 Townsgate Road, Suite 110, Westlake Village, CA 91361
- Phone
- 805-418-5006
- Investor Relations
- Derek Cole, IR Advisory Solutions · 702-785-4497 · ir@arcutis.com